Evaluation of antigen-detecting and antibody-detecting diagnostic test combinations for diagnosing melioidosis.

<h4>Background</h4>Melioidosis, an infectious disease caused by Burkholderia pseudomallei, is endemic in many tropical developing countries and has a high mortality. Here we evaluated combinations of a lateral flow immunoassay (LFI) detecting B. pseudomallei capsular polysaccharide (CPS)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Premjit Amornchai, Viriya Hantrakun, Gumphol Wongsuvan, Vanaporn Wuthiekanun, Surasakdi Wongratanacheewin, Prapit Teparrakkul, T Eoin West, David P AuCoin, Nicholas P J Day, Paul J Brett, Mary N Burtnick, Narisara Chantratitra, Direk Limmathurotsakul
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Acceso en línea:https://doaj.org/article/b60d27886d474de9a94376eb741d32c8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b60d27886d474de9a94376eb741d32c8
record_format dspace
spelling oai:doaj.org-article:b60d27886d474de9a94376eb741d32c82021-12-02T20:23:23ZEvaluation of antigen-detecting and antibody-detecting diagnostic test combinations for diagnosing melioidosis.1935-27271935-273510.1371/journal.pntd.0009840https://doaj.org/article/b60d27886d474de9a94376eb741d32c82021-11-01T00:00:00Zhttps://doi.org/10.1371/journal.pntd.0009840https://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735<h4>Background</h4>Melioidosis, an infectious disease caused by Burkholderia pseudomallei, is endemic in many tropical developing countries and has a high mortality. Here we evaluated combinations of a lateral flow immunoassay (LFI) detecting B. pseudomallei capsular polysaccharide (CPS) and enzyme-linked immunosorbent assays (ELISA) detecting antibodies against hemolysin co-regulated protein (Hcp1) or O-polysaccharide (OPS) for diagnosing melioidosis.<h4>Methodology/principal findings</h4>We conducted a cohort-based case-control study. Both cases and controls were derived from a prospective observational study of patients presenting with community-acquired infections and sepsis in northeast Thailand (Ubon-sepsis). Cases included 192 patients with a clinical specimen culture positive for B. pseudomallei. Controls included 502 patients who were blood culture positive for Staphylococcus aureus, Escherichia coli or Klebsiella pneumoniae or were polymerase chain reaction assay positive for malaria or dengue. Serum samples collected within 24 hours of admission were stored and tested using a CPS-LFI, Hcp1-ELISA and OPS-ELISA. When assessing diagnostic tests in combination, results were considered positive if either test was positive. We selected ELISA cut-offs corresponding to a specificity of 95%. Using a positive cut-off OD of 2.912 for Hcp1-ELISA, the combination of the CPS-LFI and Hcp1-ELISA had a sensitivity of 67.7% (130/192 case patients) and a specificity of 95.0% (477/502 control patients). The sensitivity of the combination (67.7%) was higher than that of the CPS-LFI alone (31.3%, p<0.001) and that of Hcp1-ELISA alone (53.6%, p<0.001). A similar phenomenon was also observed for the combination of CPS-LFI and OPS-ELISA. In case patients, positivity of the CPS-LFI was associated with a short duration of symptoms, high modified Sequential (sepsis-related) Organ Failure Assessment (SOFA) score, bacteraemia and mortality outcome, while positivity of Hcp1-ELISA was associated with a longer duration of symptoms, low modified SOFA score, non-bacteraemia and survival outcome.<h4>Conclusions/significance</h4>A combination of antigen-antibody diagnostic tests increased the sensitivity of melioidosis diagnosis over individual tests while preserving high specificity. Point-of-care tests for melioidosis based on the use of combination assays should be further developed and evaluated.Premjit AmornchaiViriya HantrakunGumphol WongsuvanVanaporn WuthiekanunSurasakdi WongratanacheewinPrapit TeparrakkulT Eoin WestDavid P AuCoinNicholas P J DayPaul J BrettMary N BurtnickNarisara ChantratitraDirek LimmathurotsakulPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 15, Iss 11, p e0009840 (2021)
institution DOAJ
collection DOAJ
language EN
topic Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
spellingShingle Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
Premjit Amornchai
Viriya Hantrakun
Gumphol Wongsuvan
Vanaporn Wuthiekanun
Surasakdi Wongratanacheewin
Prapit Teparrakkul
T Eoin West
David P AuCoin
Nicholas P J Day
Paul J Brett
Mary N Burtnick
Narisara Chantratitra
Direk Limmathurotsakul
Evaluation of antigen-detecting and antibody-detecting diagnostic test combinations for diagnosing melioidosis.
description <h4>Background</h4>Melioidosis, an infectious disease caused by Burkholderia pseudomallei, is endemic in many tropical developing countries and has a high mortality. Here we evaluated combinations of a lateral flow immunoassay (LFI) detecting B. pseudomallei capsular polysaccharide (CPS) and enzyme-linked immunosorbent assays (ELISA) detecting antibodies against hemolysin co-regulated protein (Hcp1) or O-polysaccharide (OPS) for diagnosing melioidosis.<h4>Methodology/principal findings</h4>We conducted a cohort-based case-control study. Both cases and controls were derived from a prospective observational study of patients presenting with community-acquired infections and sepsis in northeast Thailand (Ubon-sepsis). Cases included 192 patients with a clinical specimen culture positive for B. pseudomallei. Controls included 502 patients who were blood culture positive for Staphylococcus aureus, Escherichia coli or Klebsiella pneumoniae or were polymerase chain reaction assay positive for malaria or dengue. Serum samples collected within 24 hours of admission were stored and tested using a CPS-LFI, Hcp1-ELISA and OPS-ELISA. When assessing diagnostic tests in combination, results were considered positive if either test was positive. We selected ELISA cut-offs corresponding to a specificity of 95%. Using a positive cut-off OD of 2.912 for Hcp1-ELISA, the combination of the CPS-LFI and Hcp1-ELISA had a sensitivity of 67.7% (130/192 case patients) and a specificity of 95.0% (477/502 control patients). The sensitivity of the combination (67.7%) was higher than that of the CPS-LFI alone (31.3%, p<0.001) and that of Hcp1-ELISA alone (53.6%, p<0.001). A similar phenomenon was also observed for the combination of CPS-LFI and OPS-ELISA. In case patients, positivity of the CPS-LFI was associated with a short duration of symptoms, high modified Sequential (sepsis-related) Organ Failure Assessment (SOFA) score, bacteraemia and mortality outcome, while positivity of Hcp1-ELISA was associated with a longer duration of symptoms, low modified SOFA score, non-bacteraemia and survival outcome.<h4>Conclusions/significance</h4>A combination of antigen-antibody diagnostic tests increased the sensitivity of melioidosis diagnosis over individual tests while preserving high specificity. Point-of-care tests for melioidosis based on the use of combination assays should be further developed and evaluated.
format article
author Premjit Amornchai
Viriya Hantrakun
Gumphol Wongsuvan
Vanaporn Wuthiekanun
Surasakdi Wongratanacheewin
Prapit Teparrakkul
T Eoin West
David P AuCoin
Nicholas P J Day
Paul J Brett
Mary N Burtnick
Narisara Chantratitra
Direk Limmathurotsakul
author_facet Premjit Amornchai
Viriya Hantrakun
Gumphol Wongsuvan
Vanaporn Wuthiekanun
Surasakdi Wongratanacheewin
Prapit Teparrakkul
T Eoin West
David P AuCoin
Nicholas P J Day
Paul J Brett
Mary N Burtnick
Narisara Chantratitra
Direk Limmathurotsakul
author_sort Premjit Amornchai
title Evaluation of antigen-detecting and antibody-detecting diagnostic test combinations for diagnosing melioidosis.
title_short Evaluation of antigen-detecting and antibody-detecting diagnostic test combinations for diagnosing melioidosis.
title_full Evaluation of antigen-detecting and antibody-detecting diagnostic test combinations for diagnosing melioidosis.
title_fullStr Evaluation of antigen-detecting and antibody-detecting diagnostic test combinations for diagnosing melioidosis.
title_full_unstemmed Evaluation of antigen-detecting and antibody-detecting diagnostic test combinations for diagnosing melioidosis.
title_sort evaluation of antigen-detecting and antibody-detecting diagnostic test combinations for diagnosing melioidosis.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/b60d27886d474de9a94376eb741d32c8
work_keys_str_mv AT premjitamornchai evaluationofantigendetectingandantibodydetectingdiagnostictestcombinationsfordiagnosingmelioidosis
AT viriyahantrakun evaluationofantigendetectingandantibodydetectingdiagnostictestcombinationsfordiagnosingmelioidosis
AT gumpholwongsuvan evaluationofantigendetectingandantibodydetectingdiagnostictestcombinationsfordiagnosingmelioidosis
AT vanapornwuthiekanun evaluationofantigendetectingandantibodydetectingdiagnostictestcombinationsfordiagnosingmelioidosis
AT surasakdiwongratanacheewin evaluationofantigendetectingandantibodydetectingdiagnostictestcombinationsfordiagnosingmelioidosis
AT prapitteparrakkul evaluationofantigendetectingandantibodydetectingdiagnostictestcombinationsfordiagnosingmelioidosis
AT teoinwest evaluationofantigendetectingandantibodydetectingdiagnostictestcombinationsfordiagnosingmelioidosis
AT davidpaucoin evaluationofantigendetectingandantibodydetectingdiagnostictestcombinationsfordiagnosingmelioidosis
AT nicholaspjday evaluationofantigendetectingandantibodydetectingdiagnostictestcombinationsfordiagnosingmelioidosis
AT pauljbrett evaluationofantigendetectingandantibodydetectingdiagnostictestcombinationsfordiagnosingmelioidosis
AT marynburtnick evaluationofantigendetectingandantibodydetectingdiagnostictestcombinationsfordiagnosingmelioidosis
AT narisarachantratitra evaluationofantigendetectingandantibodydetectingdiagnostictestcombinationsfordiagnosingmelioidosis
AT direklimmathurotsakul evaluationofantigendetectingandantibodydetectingdiagnostictestcombinationsfordiagnosingmelioidosis
_version_ 1718374126642528256